Squarepoint’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
94,309
+61,545
| +188% | +$843K | ﹤0.01% | 1391 |
|
|
2025
Q1 | $362K | Sell |
32,764
-17,430
| -35% | -$193K | ﹤0.01% | 2092 |
|
|
2024
Q4 | $535K | Sell |
50,194
-57,451
| -53% | -$612K | ﹤0.01% | 1905 |
|
|
2024
Q3 | $1.37M | Buy |
+107,645
| New | +$1.37M | ﹤0.01% | 1298 |
|
|
2024
Q2 | – | Sell |
-63,039
| Closed | -$946K | – | 3010 |
|
|
2024
Q1 | $946K | Buy |
63,039
+3,349
| +6% | +$50.2K | ﹤0.01% | 1385 |
|
|
2023
Q4 | $895K | Buy |
+59,690
| New | +$895K | ﹤0.01% | 1401 |
|
|
2023
Q3 | – | Sell |
-10,920
| Closed | -$113K | – | 2887 |
|
|
2023
Q2 | $113K | Buy |
+10,920
| New | +$113K | ﹤0.01% | 2194 |
|
|
2021
Q3 | – | Sell |
-21,554
| Closed | -$329K | – | 2762 |
|
|
2021
Q2 | $329K | Buy |
+21,554
| New | +$329K | ﹤0.01% | 1902 |
|
|
2019
Q4 | – | Sell |
-9,289
| Closed | -$221K | – | 2702 |
|
|
2019
Q3 | $221K | Buy |
9,289
+3,220
| +53% | +$76.6K | ﹤0.01% | 1943 |
|
|
2019
Q2 | $218K | Sell |
6,069
-7,171
| -54% | -$258K | ﹤0.01% | 2007 |
|
|
2019
Q1 | $489K | Buy |
+13,240
| New | +$489K | 0.01% | 1471 |
|